ASX/RHT (ASX/RHT)

Australian Securities Exchange: ASX/RHT · AUD

A$0.07

+0.00 (0.0%)· Recorded snapshot

Market cap	35.3M
Revenue (ttm)	15.8M
Net income (ttm)	1.5M
EPS (ttm)	A$0.00
Shares out	477.1M
P/E (trailing)	23.9x
Volume	402,576
Beta	1.01

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15.8M
Net income (ttm): 1.5M
EPS (ttm): A$0.00
P/E (trailing): 23.9x
Market cap: 35.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E23.9

P25 n/aP50 n/aP75 n/a

ROE14.8

P25 n/aP50 n/aP75 n/a

ROIC8.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/RHT indicators

Market & fundamental data

Available fields

230

Groups with data

Currency

AUD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-26
Employees	16
Enterprise value	AUD 34.3M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1987
Industry	Health Information Services
Is primary listing	Yes
ISIN number	AU000000RHT2
Last earnings date	2026-08-28
Last refreshed	2026-10-30
Last stock split date	2003-10-15
Last stock split type	Reverse
Market cap	AUD 35.3M
Next earnings date	2026-11-26
Price	AUD 0.07
Price currency	AUD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-30
Symbol	asx/RHT
Website	https://www.resonancehealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	4.19%
EV/Earnings	22.65x
EV/EBIT	18.61x
EV/EBITDA	13.35x
EV/FCF	12.3x
EV/Sales	2.18x
FCF / EV yield	8.13%
FCF yield	7.89%
Graham number	0.04031
Graham upside	-45.53%
Industry forward P/E	143.98x
Industry P/E	203.58x
Lynch fair value	AUD 0.06
Lynch upside	-12.46%
P/(FCF - SBC) ratio	13.71x
P/(OCF - SBC) ratio	13.22x
P/B ratio	3.18x
P/E ratio	23.87x
P/FCF ratio	12.67x
P/OCF ratio	12.25x
P/S ratio	2.24x
Price / tangible book value	8.04x
Price/EBITDA ratio	15.36x
Sector forward P/E	34.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	11.69%
EBITDA margin	14.59%
FCF margin	17.69%
Gross margin	96.58%
Operating margin	11.69%
Pretax margin	6.98%
Profit margin	9.61%
Profit per employee	AUD 94,569
Profitable quarters	2
Profitable years	1
Revenue per employee	AUD 984,494
ROA	6.28%
ROA (5Y)	-3.26%
ROCE	15.15%
ROE	14.76%
ROE (5Y)	-3.68%
ROIC	8.19%
SBC / revenue	1.34%
Tax / revenue	-2.63%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	-97.63%
EPS growth 5Y	19%
EPS growth quarters	2
EPS growth years	1
FCF growth	245.98%
FCF growth (QoQ)	1,835.44%
FCF growth 5Y	19.81%
Gross profit growth	42.02%
Gross profit growth (Q)	31.56%
Gross profit growth 3Y	51.16%
Gross profit growth 5Y	32.12%
Net income growth (QoQ)	-96.79%
Net income growth 5Y	20.9%
Net income growth quarters	2
Net income growth years	1
OCF growth	130.77%
OCF growth (Q)	995.43%
OCF growth (QoQ)	1,462%
OCF growth 10Y	47.05%
OCF growth 5Y	19.7%
Operating income growth 5Y	35.73%
Revenue growth	42.26%
Revenue growth (Q)	32.65%
Revenue growth (QoQ)	-2.49%
Revenue growth 10Y	19.98%
Revenue growth 3Y	52.93%
Revenue growth 5Y	33.04%
Revenue growth quarters	9
Revenue growth years	9

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -94,772
Depreciation and amortization	AUD 457,248
EBIT	AUD 1.8M
EBITDA	AUD 2.3M
EPS	AUD 0.00
FCF per share	AUD 0.01
Financing cash flow	AUD -597,538
Free cash flow	AUD 2.8M
Free cash flow minus SBC	AUD 2.6M
Gross profit	AUD 15.2M
Income taxes	AUD -413,631
Investing cash flow	AUD -300,526
Net borrowing	AUD -629,141
Net cash flow	AUD 1.9M
Net income	AUD 1.5M
Operating cash flow minus SBC	AUD 2.7M
Operating income	AUD 1.8M
Revenue	AUD 15.8M
Stock-based compensation	AUD 210,368

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1.93
Book value per share	AUD 0.02
Debt / EBITDA	1.48
Debt / equity	0.34
Debt / FCF	1.37
Goodwill	AUD 5.3M
Interest coverage	5.44
Long-term assets	AUD 11.3M
Long-term liabilities	AUD 1M
Net cash (debt)	AUD 1M
Net cash / market cap	2.94%
Net debt / EBITDA	-0.45
Net debt / equity	-0.09
Net debt / FCF	-0.37
Piotroski F-Score	5
Property, plant and equipment	AUD 1.8M
Shareholders' equity	AUD 11.1M
Tangible book value	AUD 4.4M
Tangible book value per share	AUD 0.01
Total assets	AUD 18.7M
Total cash	AUD 4.8M
Total debt	AUD 3.8M
Total liabilities	AUD 7.6M
WACC	9.51%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.86
Current assets	AUD 7.5M
Current liabilities	AUD 6.6M
Current ratio	1.13
Net working capital	AUD -1.2M
Quick ratio	1.11
Working capital	AUD 876,158
Working capital turnover	13.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-6.28%
Shareholder yield	-6.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	174.07%
10Y return CAGR	10.61%
10Y total return	174.07%
150-day SMA	AUD 0.05
15Y price change	393.33%
15Y return CAGR	11.31%
15Y total return	398.99%
1D price change	0%
1M price change	2.78%
1M total return	2.78%
1Y price change	42.31%
1Y return CAGR	42.34%
1Y total return	42.31%
20-day SMA	AUD 0.08
200-day SMA	AUD 0.05
20Y price change	174.07%
20Y return CAGR	5.23%
20Y total return	177.22%
3M price change	23.33%
3M total return	23.33%
3Y price change	25.42%
3Y return CAGR	7.84%
3Y total return	25.42%
50-day SMA	AUD 0.07
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 0.09
52-week high date	2026-10-14
52-week low	AUD 0.04
52-week low date	2026-03-27
5Y price change	-29.52%
5Y return CAGR	-6.76%
5Y total return	-29.52%
6M price change	57.45%
6M total return	57.45%
All-time high	AUD 45.50
All-time high date	1996-09-10
All-time low	AUD 0.01
All-time low date	2008-10-13
Average true range (ATR)	AUD 0.00
Average volume	858.7K
Beta (1Y)	0.91
Beta (2Y)	1.07
Beta (5Y)	1.01
Change from 52-week high	-13.95%
Change from 52-week low	111.43%
Change from all-time high	-99.84%
Change from all-time low	957.14%
Change from open	0%
Day's gap	0%
Dollar volume	AUD 29,791
High price	AUD 0.07
Low price	AUD 0.07
Monthly RSI	61.24
Open price	AUD 0.07
Previous close	AUD 0.07
Price vs 150-day SMA	40.68%
Price vs 20-day SMA	-4.02%
Price vs 200-day SMA	44.81%
Price vs 50-day SMA	9.31%
Relative volume	0.48
RSI	50.73
Sharpe ratio	1.16
Sharpe ratio (3Y)	0.44
Sharpe ratio (5Y)	0.21
Sortino ratio	1.81
Sortino ratio (3Y)	0.79
Sortino ratio (5Y)	0.43
Volume	402.6K
Weekly RSI	64.98
YTD price change	51.02%
YTD total return	51.02%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	287.8M
Shares change (QoQ)	-1.95%
Shares change (YoY)	6.28%
Shares held by insiders	35.6%
Shares held by institutions	0.73%
Shares outstanding	477.1M

Deeper analysis on ASX/RHT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/RHT report

Is a complete ASX/RHT research report available?

No complete published report is available for asx/RHT (ASX/RHT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/RHT (ASX/RHT)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/RHT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/RHT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/RHT

Frequently asked questions